Physician profile
Michael Silpa
NPI 1679684195
$3,108.13
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $665 · 2020: $928 · 2021: $1,515.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $684.23 | 2019-2021 | |
| Janssen Biotech, INC. | $657.81 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $470.32 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $229.40 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $179.97 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $117.49 | 2020-2021 | |
| Pfizer INC. | $116.29 | 2019-2021 | |
| Dova Pharmaceuticals | $113.18 | 2019 | |
| Daiichi Sankyo INC. | $110.37 | 2020-2021 | |
| Janssen Scientific Affairs, LLC | $105.09 | 2019 | |
| Intercept Pharmaceuticals, INC. | $87.19 | 2019-2021 | |
| Gilead Sciences, INC. | $66.81 | 2020 | |
| Concordia Pharmaceuticals INC. | $38.60 | 2019 | |
| Allergan, INC. | $33.60 | 2019-2020 | |
| Braintree Laboratories, INC. | $22.54 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $19.62 | 2019 | |
| Celgene Corporation | $16.48 | 2021 | |
| Amag Pharmaceuticals, INC. | $14.57 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $12.53 | 2019 | |
| Napo Pharmaceuticals INC | $12.04 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Silpa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.